Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Controlling Hyperactive Immunity with Long-lasting Lymphocytes (CHILL)

Introducing CHILL:

A research Study exploring a potential new one time treatment for difficult to treat rheumatoid arthritis or scleroderma.

What is CHILL?

CHILL1

What is QEL-005?

What is a clinical study?

When scientists discover a promising new molecule or treatment, many things must be done before it reaches the public. Carefully controlled research studies are legally required before a new treatment can be used in humans to assess:

Safety - including side effects
Clinical activity - how it acts in the body
Dose - the optimal amount
Efficacy - ability to have a therapeutic effect

For more information on CHILL please follow the link below:

www.chillstudy.life

Please contact emcrf@ouh.nhs.uk for more information